Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
46.3M
-
Shares change
-
-225K
-
Total reported value, excl. options
-
$79.6M
-
Value change
-
-$708K
-
Put/Call ratio
-
3.13
-
Number of buys
-
33
-
Number of sells
-
-29
-
Price
-
$1.72
Significant Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q2 2017
86 filings reported holding IDRA - IDERA PHARMACEUTICALS INC - COM NEW as of Q2 2017.
IDERA PHARMACEUTICALS INC - COM NEW (IDRA) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.3M shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (10.3M shares), BlackRock Inc. (6.46M shares), VANGUARD GROUP INC (5.18M shares), Broadfin Capital, LLC (3.85M shares), FMR LLC (3.27M shares), NATIXIS (3.15M shares), JPMORGAN CHASE & CO (2.31M shares), STATE STREET CORP (1.79M shares), NORTHERN TRUST CORP (1.27M shares), and Point72 Asset Management, L.P. (1M shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.